Probability of disease progression after diagnosis of molecular relapse (n = 107). Progression was defined by finding evidence of cytogenetic or hematologic relapse in a patient who lacked such evidence when molecular relapse was diagnosed. Vertical lines represent patients in MR who had not progressed.